v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 30,174 $ 676,373,822 $ (640,882,035) $ 35,521,961
Balance (in Shares) at Dec. 31, 2024 30,174,202      
Stock based compensation 3,572,769 3,572,769
Issuance of restricted common stock $ 3,017 902,209 905,226
Issuance of restricted common stock (in Shares) 3,017,420      
Net loss (17,559,465) (17,559,465)
Balance at Mar. 31, 2025 $ 33,191 680,848,800 (658,441,500) 22,440,491
Balance (in Shares) at Mar. 31, 2025 33,191,622      
Balance at Dec. 31, 2025 $ 73,333 784,705,878 (698,267,198) 86,512,013
Balance (in Shares) at Dec. 31, 2025 73,333,622      
Stock based compensation 956,186 956,186
Issuance of restricted common stock (in Shares) 2,082,032      
Proceeds from issuance of common stock, net $ 29,475 150,352,510 150,381,985
Proceeds from issuance of common stock, net (in Shares) 29,474,569      
ATM Fees   (65,651)   (65,651)
Cashless exercise of pre-funded warrants for common stock $ 2,082 (2,082)  
Cashless exercise of pre-funded warrants for common stock (in Shares) 2,082,032      
Net loss (19,051,956) (19,051,956)
Balance at Mar. 31, 2026 $ 104,890 $ 935,946,841 $ (717,319,154) $ 218,732,577
Balance (in Shares) at Mar. 31, 2026 104,890,223